Stocks › NVAX
NOVAVAX INC
NVAX·Nasdaq·
United States·USD
United States·USD$11.32
-1.24 (-9.87%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
NVAX
NOVAVAX INC · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
NVAXS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of NVAX by members of U.S. Congress · 2 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Pat RobertsSenate · R · KS |
NVAXNOVAVAX INC · Stock |
Sale $1,001 - $15,000 |
Nov 5, 2020 | Oct 13, 2020 | Filing ↗ |
| Pat RobertsSenate · R · KS |
NVAXNOVAVAX INC · Stock |
Purchase $1,001 - $15,000 |
Aug 30, 2020 | Aug 17, 2020 | Filing ↗ |
Whale Activity
Position changes in NVAX reported for 2026-06-30 by 10 tracked institutional filers
- Increased6
- New0
- Held1
- Decreased3
- Closed0
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 13.9M | $131.4M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7.6M | $71.7M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.3M | $68.4M | increased |
| D. E. Shaw & Co., Inc. | 5.7M | $53.2M | decreased |
| TWO SIGMA INVESTMENTS, LP | 4.1M | $38.5M | increased |
| MILLENNIUM MANAGEMENT LLC | 1.8M | $16.7M | decreased |
| CITADEL ADVISORS LLC | 1.7M | $16.0M | increased |
| Point72 Asset Management, L.P. | 664.3K | $6.3M | decreased |
| Point72 Asset Management, L.P. | 4.4M | $5.2M | held |
| RENAISSANCE TECHNOLOGIES LLC | 501.8K | $4.7M | increased |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by NVAX insiders, by quarter · Form 4
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
1,498 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Rodgers Richard JDirector | Option exercise | +18.9K | — | — | Jun 20, 2026 | Form 4 ↗ |
| King Rachel K.Director | Option exercise | +18.9K | — | — | Jun 20, 2026 | Form 4 ↗ |
| DOUGLAS RICHARDDirector | Option exercise | +18.9K | — | — | Jun 20, 2026 | Form 4 ↗ |
| MCGLYNN MARGARET GDirector | Option exercise | +18.9K | — | — | Jun 20, 2026 | Form 4 ↗ |
| MOTT DAVID MDirector | Option exercise | +18.9K | — | — | Jun 20, 2026 | Form 4 ↗ |
| Alton Gregg HDirector | Option exercise | +18.9K | — | — | Jun 20, 2026 | Form 4 ↗ |
| Newton Charles W.Director | Option exercise | +9,520 | $0.00 | $0 | Apr 25, 2026 | Form 4 ↗ |
| Shiver John W.Director | Option exercise | +7,947 | $0.00 | $0 | Mar 10, 2026 | Form 4 ↗ |
| Kelly James PatrickEVP, CFO and Treasurer | Tax withholding | −5,904 | $9.98 | $59K | Mar 7, 2026 | Form 4 ↗ |
| Kelly James PatrickEVP, CFO and Treasurer | Option exercise | +12.2K | $0.00 | $0 | Mar 7, 2026 | Form 4 ↗ |
| Kelly James PatrickEVP, CFO and Treasurer | Tax withholding | −20.9K | $9.49 | $198K | Mar 3, 2026 | Form 4 ↗ |
| Kelly James PatrickEVP, CFO and Treasurer | Option exercise | +43.2K | $0.00 | $0 | Mar 3, 2026 | Form 4 ↗ |
| Jacobs John CPresident and CEO · Director | Tax withholding | −69.3K | $9.49 | $658K | Mar 3, 2026 | Form 4 ↗ |
| Jacobs John CPresident and CEO · Director | Option exercise | +150.2K | $0.00 | $0 | Mar 3, 2026 | Form 4 ↗ |
| O'Hara ElaineEVP, Chief Strategy Officer | Tax withholding | −22.4K | $9.49 | $213K | Mar 3, 2026 | Form 4 ↗ |
| O'Hara ElaineEVP, Chief Strategy Officer | Option exercise | +56.3K | $0.00 | $0 | Mar 3, 2026 | Form 4 ↗ |
| Casey Mark JEVP, Chief Legal Officer | Tax withholding | −11.4K | $9.49 | $108K | Mar 3, 2026 | Form 4 ↗ |
| Casey Mark JEVP, Chief Legal Officer | Option exercise | +37.5K | $0.00 | $0 | Mar 3, 2026 | Form 4 ↗ |
| Draghia-Akli RuxandraEVP, Research & Development | Tax withholding | −11.3K | $9.49 | $107K | Mar 3, 2026 | Form 4 ↗ |
| Draghia-Akli RuxandraEVP, Research & Development | Option exercise | +26.7K | $0.00 | $0 | Mar 3, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding NVAX · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 7.5M | $70.9M | 0.66% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 5.2M | $49.0M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 3.9M | $36.9M | 0.04% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 3.8M | $35.5M | 0.02% | Jun 30, 2026 |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 2.2M | $20.4M | 0.04% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.9M | $17.8M | 0.02% | Jun 30, 2026 |
| iShares Russell 2000 Value ETF iShares Trust | 1.4M | $13.5M | 0.09% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 1.7M | $12.2M | 0.04% | Jul 31, 2026 |
| iShares Biotechnology ETF iShares Trust | 1.1M | $10.5M | 0.12% | Jun 30, 2026 |
| PIMCO RAE US Small Fund PIMCO Equity Series | 1.0M | $9.6M | 0.25% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list NVAX's shares (CUSIP 670002401), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- STATE STREET CORPORATIONSCHEDULE 13G · passive (13G) · 11.7M shares7.1%
Aug 7, 2026 · ↗ - Himanshu H. ShahSCHEDULE 13D/A · activist (13D) · 14.8M shares9.0%
May 15, 2026 · ↗ - Shah Capital Opportunity Fund LPSCHEDULE 13D/A · activist (13D) · 14.0M shares8.5%
May 15, 2026 · ↗ - Shah Capital ManagementSCHEDULE 13D/A · activist (13D) · 14.7M shares8.9%
May 15, 2026 · ↗ - BANK OF AMERICA CORP /DE/SCHEDULE 13G/A · passive (13G) · 6.7M shares4.1%
Apr 27, 2026 · ↗ - BANK OF AMERICA CORP /DE/SCHEDULE 13G · passive (13G) · 8.3M shares5.1%
Feb 11, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming novavax as client
Government Contracts
Federal awards to NOVAVAX INC · USAspending
No federal contract awards found for NOVAVAX INC.
U.S. Patents
Recent USPTO applications naming NOVAVAX INC
No USPTO patent applications found for NOVAVAX INC.
Annual Financials
From NVAX's 10-K filings · XBRL
No annual XBRL figures on record for NVAX. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
- 1-for-20Reverse splitMay 10, 2019
Split dates and ratios from the price history · Close Prices from Tiingo.com
About NOVAVAX INC
From SEC EDGAR company records
Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersGAITHERSBURG, MD
IncorporatedDE
SEC CIK0001000694 ↗